Nicholas T. Olney
Neurology | Neuromusculoskeletal Medicine
5050 Northeast Hoyt Street
Suite 315
Portland, OR 97213
Suite 315
Portland, OR 97213
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: May 14, 2025
Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium dataset.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: April 02, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2025
Facilitators and challenges in the implementation of the Care Ecosystem at six clinical sites in the United States: A qualitative study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 14, 2025
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Journal: The Lancet. Neurology
Published: November 22, 2023
The natural history of ALS: Baseline characteristics from a multicenter clinical cohort.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 18, 2023
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design.
Journal: Neurodegenerative disease management
Published: November 24, 2021
Last Updated: 09/26/2026